115
Participants
Start Date
November 19, 2020
Primary Completion Date
April 28, 2021
Study Completion Date
April 28, 2021
Brequinar
Dihydroorotate dehydrogenase inhibitor (DHODHi)
Placebo
Placebo capsules
Monroe Biomedical Research, Monroe
Wilmington Health, Wilmington
VitaLink Research, Spartanburg
VitaLink - Gaffney, Gaffney
Self Regional Healthcare Research Center - Self Medical Group, Greenwood
Doral Medical Research, Doral
Central Alabama Research, Homewood
Clinical Trials Center of Middle Tennessee, Franklin
Remington-Davis, Inc., Columbus
Toledo Institute of Clinical Research, Toledo
Centex Studies, Inc. - McAllen, McAllen
Synexus Clinical Research US, Inc. - Olympus Family Medicine, Salt Lake City
Ark Clinical Research, Long Beach
South Jersey Infectious Disease, Somers Point
Lead Sponsor
Clear Creek Bio, Inc.
INDUSTRY